Sign in to view content

Characteristics and the Need for Supplementation Following 0.19mg Fluocinolone Acetonide (FAc) in Diabetic Macular Edema (DME) Patients

Victor Hugo Gonzalez, MD

Video
Published 2021

Related

The Translation of CST to Visual Function: Persistent DME and QOL Measures With FAc Implants in the FAME Study
Michael A. Singer, MD
Annual Meeting Talks
2018
One-Year Results of Fluocinolone Acetonide Intravitreal Implant For Diabetic Macular Edema in Highly Treated Eyes
Sumit P. Shah, MD, FACS, FASRS
On Demand Cases, Courses, and Papers
2017
Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew Starr, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more